Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors

NCT04510792 is registered in ClinicalTrials.gov with Portsmouth Hospitals NHS Trust as lead sponsor.

NCT NCT04510792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04510792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
Lead sponsor
Portsmouth Hospitals NHS Trust
Phase
Observational
Overall status
Withdrawn
Start date
July 12, 2021
Completion date
July 12, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia